To be immunogenic, or not to be: that's the iPSC question
- PMID: 23561437
- DOI: 10.1016/j.stem.2013.03.008
To be immunogenic, or not to be: that's the iPSC question
Abstract
The unexpected finding that autologous induced pluripotent stem cell (iPSC)-derived teratomas are immunogenic in syngeneic hosts sparked pessimism over their therapeutic potential; however, two recent reports (Guha et al., 2013 and Araki et al., 2013; the latter in this issue of Cell stem cell) contradict previous findings, showing no immunogenicity of in vitro differentiated syngeneic iPS-derived cells and supporting their safety.
Copyright © 2013 Elsevier Inc. All rights reserved.
Comment on
-
Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.Nature. 2013 Feb 7;494(7435):100-4. doi: 10.1038/nature11807. Epub 2013 Jan 9. Nature. 2013. PMID: 23302801
-
Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells.Cell Stem Cell. 2013 Apr 4;12(4):407-12. doi: 10.1016/j.stem.2013.01.006. Epub 2013 Jan 24. Cell Stem Cell. 2013. PMID: 23352605
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
